Widely used:Recently Viewed
Clear AllToday’s Range
52 Week Range
Liquidity
Market cap
₹13 Cr
P/E Ratio
27.26
P/B Ratio
1.4
Industry P/E
36.17
Debt to Equity
0.06
ROE
5.7 %
ROCE
7.67 %
Div. Yield
0 %
Book Value
37.32
EPS
1.91
CFO
₹5.82 Cr
EBITDA
₹4.39 Cr
Net Profit
₹2.31 Cr
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|
|---|---|---|---|---|---|---|---|
|
Colinz Lab
| -25.37 | -28.13 | -7.87 | 32.03 | 26.61 | 39.61 | 11.59 |
|
BSE Healthcare
| -6.54 | 1.91 | 1.42 | 18.70 | 20.14 | 22.31 | 10.08 |
|
BSE Small Cap
| -13.49 | 1.63 | -3.38 | 0.28 | 18.33 | 33.99 | 15.77 |
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
|
|---|---|---|---|---|---|---|
|
Colinz Lab
| 74.40 | -6.98 | 55.52 | 96.12 | 42.70 | 7.87 |
|
BSE Small Cap
| 29.04 | 47.52 | -1.80 | 62.77 | 32.11 | -6.85 |
|
BSE Healthcare
| 43.09 | 36.97 | -12.10 | 20.87 | 61.45 | -3.55 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
3Y Avg -- 5Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price (₹) | Market Cap (₹ Cr) | P/E Ratio | ROE |
|---|---|---|---|---|
| 713.35 | 6,465.87 | 25.93 | 13.8 | |
| 1,130.60 | 9,255.28 | 76.25 | 12.96 | |
| 455.80 | 11,034.53 | 23.03 | 14.4 | |
| 884.55 | 5,059.83 | 39.71 | 14.76 |
No Review & Analysis are available.
Colinz Laboratories Limited manufactures and markets pharmaceutical formulations in India It provides pharmaceutical formulations in the dosage forms of tablets, capsules, granules, liquid orals, injectables, ointments, creams, etc.; and specialized... products for gynecology, cardiology, gastroenterology, etc. The company's allopathy products include oncology products and antiritrovirals; and products for other therapeutic areas, such as antibiotics, anti-pyretics, anti-fungals, anti-malarials, anti-virals, anti-manics, anti-convulsants, anti-migraines, anti-allergics, anti-diarrhoeals, anti-inflammatory, anti-piles, anthelmintics, anti-emetics, anti-spasmodics, infestations, sedatives, cerebral activators, ulcer healing agents, laxatives, probiotics, digestive enzymes, topical steroids, ear/eye drops, hormone, sunscreens and vitamins, etc., as well as drugs used in protozoal infestations and neuropathy. It also provides ayurvedic products, including anti-diarrhoeals, anti-pyretics, anti-inflammatories, anti-spasmodics, cough syrups, apetite stimulating agents, memory boosters, anti-piles, antacids, liver tonics, ulcer healing agents, digestive agents, ear drops, uterine tonics, anti-diabetics, and general tonics, as well as drugs to treat oligospermia and erectile dysfunction. In addition, the company offers nutraceuticals that include spirulina tabs/caps; spirulina with vitamins and minerals; omega 3 fatty acids caps in softgel; codliver oil with vitamin caps in soft gel; collagen, glucosamine, and chondroitin tabs; amino acids tabs/caps; L-arginine with proantocyanidin granules; and hair growth formulas, etc. The company was founded in 1986 and is based in Mumbai, India. Read more
Incorporated
1986
Chairman
--
Managing Director
--
Headquarters
Mumbai, Maharashtra
Website
Our rating system has guided millions of investors in the past 20 years.
Annual Reports
The total asset value of Colinz Laboratories Ltd stood at ₹ 12 Cr as on 31-Dec-24
The share price of Colinz Laboratories Ltd is ₹52.06 (BSE) as of 30-Apr-2025 IST. Colinz Laboratories Ltd has given a return of 26.61% in the last 3 years.
Colinz Laboratories Ltd has a market capitalisation of ₹ 13 Cr as on 30-Apr-2025. As per Value Research classification, it is a Small Cap company.
The P/B ratio of Colinz Laboratories Ltd is 1.40 times as on 30-Apr-2025, a 60% discount to its peers’ median range of 3.54 times.
The P/E ratio of Colinz Laboratories Ltd is 27.26 times as on 30-Apr-2025, a 25% discount to its peers’ median range of 36.17 times.
Step 1. Open a demat account through a broker. You would need to provide your email, PAN, bank account details, aadhar details, etc., for KYC
Step 2. Sign in to the broker’s application through a mobile app or website. Use the Login ID and password provided by your broker.
Step 3. Transfer funds from your bank account into the wallet present in your brokerage account.
Step 4. Search for the Colinz Laboratories Ltd and enter the required number of quantities and click on buy to purchase the shares of Colinz Laboratories Ltd.
Colinz Laboratories Limited manufactures and markets pharmaceutical formulations in India It provides pharmaceutical formulations in the dosage forms of tablets, capsules, granules, liquid orals, injectables, ointments, creams, etc.; and specialized products for gynecology, cardiology, gastroenterology, etc. The company's allopathy products include oncology products and antiritrovirals; and products for other therapeutic areas, such as antibiotics, anti-pyretics, anti-fungals, anti-malarials, anti-virals, anti-manics, anti-convulsants, anti-migraines, anti-allergics, anti-diarrhoeals, anti-inflammatory, anti-piles, anthelmintics, anti-emetics, anti-spasmodics, infestations, sedatives, cerebral activators, ulcer healing agents, laxatives, probiotics, digestive enzymes, topical steroids, ear/eye drops, hormone, sunscreens and vitamins, etc., as well as drugs used in protozoal infestations and neuropathy. It also provides ayurvedic products, including anti-diarrhoeals, anti-pyretics, anti-inflammatories, anti-spasmodics, cough syrups, apetite stimulating agents, memory boosters, anti-piles, antacids, liver tonics, ulcer healing agents, digestive agents, ear drops, uterine tonics, anti-diabetics, and general tonics, as well as drugs to treat oligospermia and erectile dysfunction. In addition, the company offers nutraceuticals that include spirulina tabs/caps; spirulina with vitamins and minerals; omega 3 fatty acids caps in softgel; codliver oil with vitamin caps in soft gel; collagen, glucosamine, and chondroitin tabs; amino acids tabs/caps; L-arginine with proantocyanidin granules; and hair growth formulas, etc. The company was founded in 1986 and is based in Mumbai, India.
The promoters of Colinz Laboratories Ltd are MANI L S and VIJAYA MANI. They collectively own 49.56 per cent of the total equity. The chairman of the company is
There is no promoter pledging in Colinz Laboratories Ltd.
Some of the close peers are:
| Company | Market Cap(₹ Cr) |
|---|---|
|
10,968
|
|
|
8,743
|
|
|
6,661
|
|
|
5,068
|
| Colinz Laboratories Ltd. | Ratios |
|---|---|
|
Return on equity(%)
|
5.26
|
|
Operating margin(%)
|
5.85
|
|
Net Margin(%)
|
6.84
|
|
Dividend yield(%)
|
0
|
Yes, TTM profit after tax of Colinz Laboratories Ltd was ₹0 Cr.
₹-2.21
(
